Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Training in Bariatric and Metabolic Endoscopic Therapies

  • Jirapinyo, Pichamol (Division of Gastroenterology, Brigham and Women's Hospital) ;
  • Thompson, Christopher C. (Division of Gastroenterology, Brigham and Women's Hospital)
  • Received : 2018.07.01
  • Accepted : 2018.09.18
  • Published : 2018.09.30
⟨ Previous Next ⟩

Abstract

Bariatric endoscopy is an emerging subspecialty for gastroenterologists encompassing a broad array of procedures including primary endoscopic bariatric and metabolic therapies and the treatment of complications of bariatric surgery. In addition, comprehensive understanding of lifestyle intervention and pharmacotherapy are essential to successful outcomes. This review summarizes goals and steps of training for this emerging field.

Keywords

References

  1. World Health Organization. Obesity and overweight [Internet]. Geneva: WHO; c2018 [updated 2018 Feb 16; cited 2018 Jun 29]. Available from: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
  2. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014;63(25 Pt B):2985-3023. https://doi.org/10.1016/j.jacc.2013.11.004
  3. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) 2014;22:5-13. https://doi.org/10.1002/oby.20662
  4. Igel LI, Kumar RB, Saunders KH, Aronne LJ. Practical use of pharmacotherapy for obesity. Gastroenterology 2017;152:1765-1779. https://doi.org/10.1053/j.gastro.2016.12.049
  5. Corcelles R, Boules M, Froylich D, et al. Total weight loss as the out-come measure of choice after Roux-en-Y gastric bypass. Obes Surg 2016;26:1794-1798. https://doi.org/10.1007/s11695-015-2022-y
  6. Ponce J, Nguyen NT, Hutter M, Sudan R, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg Obes Relat Dis 2015;11:1199-1200. https://doi.org/10.1016/j.soard.2015.08.496
  7. Abu Dayyeh BK, Eaton LL, Woodman G, et al. A randomized, multi-center study to evaluate the safety and effectiveness of an intragastric balloon as an adjunct to a behavioral modification program, in comparison with a behavioral modification program alone in the weight management of obese subjects. Gastrointest Endosc 2015;81(5 Suppl):AB147.
  8. Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015;11:874-881. https://doi.org/10.1016/j.soard.2014.12.006
  9. Sullivan S, Swain JM, Woodman G, et al. The obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6- month randomized sham controlled trial. Gastroenterology 2016;150(4 Suppl):S1267.
  10. US Food and Drug Administration. Summary of safety and effectiveness data (SSED): $ORBERA^{TM}$ intragastric balloon system [Internet]. Silver Spring (MD): FDA; c2015 [updated 2015 Aug 5; cited 2018 Sep 19]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140008b.pdf.
  11. US Food and Drug Administration. Summary of safety and effectiveness data (SSED): obalon balloon system [Internet]. Silver Spring (MD): FDA; c2016 [updated 2016 Sep 8; cited 2018 Sep 19]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160001b.pdf.
  12. US Food and Drug Administration. Summary of safety and effectiveness data (SSED): $ReShape^{TM}$ integrated dual balloon system [Internet]. Silver Spring (MD): FDA; c2015 [updated 2015 Jul 28; cited 2018 Sep 19]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140012b.pdf.
  13. Jirapinyo P, Slattery J, Ryan MB, Abu Dayyeh BK, Lautz DB, Thompson CC. Evaluation of an endoscopic suturing device for transoral outlet reduction in patients with weight regain following Roux-en-Y gastric bypass. Endoscopy 2013;45:532-536. https://doi.org/10.1055/s-0032-1326638
  14. Sharaiha RZ, Kedia P, Kumta N, et al. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy 2015;47:164-166.
  15. Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up. Gastrointest Endosc 2016;83:776-779. https://doi.org/10.1016/j.gie.2015.08.039
  16. Lopez-Nava G, Galvao M, Bautista-Castano I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open 2016;4:E222-E227. https://doi.org/10.1055/s-0041-110771
  17. Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017;27:2649-2655. https://doi.org/10.1007/s11695-017-2693-7
  18. Miller K, Turro R, Greve JW, Bakker CM, Buchwald JN, Espinos JC. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy. Obes Surg 2017;27:310-322. https://doi.org/10.1007/s11695-016-2295-9
  19. Lopez-Nava G, Bautista-Castano I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis 2015;11:861-865. https://doi.org/10.1016/j.soard.2014.09.026
  20. Thompson CC, Abu Dayyeh BK, Kushner R, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 2017;112:447-457. https://doi.org/10.1038/ajg.2016.500
  21. Jirapinyo P, Thompson CC. Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action. Clin Gastroenterol Hepatol 2017;15:619-630. https://doi.org/10.1016/j.cgh.2016.10.021
  22. Foxx-Orenstein AE. Gastrointestinal symptoms and diseases related to obesity: an overview. Gastroenterol Clin North Am 2010;39:23-37. https://doi.org/10.1016/j.gtc.2009.12.006
  23. Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology 2017;152:1656-1670. https://doi.org/10.1053/j.gastro.2016.12.052
  24. Jirapinyo P, Kumar N, Thompson CC. Patients with Roux-en-Y gastric bypass require increased sedation during upper endoscopy. Clin Gastroenterol Hepatol 2015;13:1432-1436. https://doi.org/10.1016/j.cgh.2015.02.042
  25. ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis 2011;7:672-682. https://doi.org/10.1016/j.soard.2011.09.008
  26. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 2017;152:1791-1801. https://doi.org/10.1053/j.gastro.2017.01.044
  27. Kushner RF, Brittan D, Cleek J, et al. The American board of obesity medicine: five-year report. Obesity (Silver Spring) 2017;25:982-984. https://doi.org/10.1002/oby.21828
  28. Patel LY, Lapin B, Brown CS, et al. Outcomes following 50 consecutive endoscopic gastrojejunal revisions for weight gain following Roux-en-Y gastric bypass: a comparison of endoscopic suturing techniques for stoma reduction. Surg Endosc 2017;31:2667-2677. https://doi.org/10.1007/s00464-016-5281-3
  29. Jirapinyo P, Kroner PT, Thompson CC. Purse-string transoral outlet reduction (TORe) is effective at inducing weight loss and improvement in metabolic comorbidities after Roux-en-Y gastric bypass. Endoscopy 2018;50:371-377. https://doi.org/10.1055/s-0043-122380
  30. Schulman AR, Kumar N, Thompson CC. Transoral outlet reduction: a comparison of purse-string with interrupted stitch technique. Gastrointest Endosc 2018;87:1222-1228. https://doi.org/10.1016/j.gie.2017.10.034
  31. Jirapinyo P, Kumar N, Thompson CC. Endoscopic suturing: indications, procedural complexity and learning curve. Gastrointest Endosc 2016;83(5 Suppl):AB494-AB495.
  32. Skinner MJ, Aihara H, Jirapinyo P, Thompson CC. Development and initial validation of a fully synthetic and reusable endoscopic suturing simulator. Gastrointest Endosc 2017;85(5 Suppl):AB502-AB503.
  33. Acosta A, Streett S, Kroh MD, et al. White paper AGA: POWER - practice guide on obesity and weight management, education, and resources. Clin Gastroenterol Hepatol 2017;15:631-649.e10. https://doi.org/10.1016/j.cgh.2016.10.023
  34. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015;82:425-438.e5. https://doi.org/10.1016/j.gie.2015.03.1964
  35. Berthoud HR, Klein S. Advances in obesity: causes, consequences, and therapy. Gastroenterology 2017;152:1635-1637. https://doi.org/10.1053/j.gastro.2017.03.045

Cited by

  1. Endoscopy training in Korea vol.34, pp.2, 2018, https://doi.org/10.3904/kjim.2019.028
  2. Endoscopic management of weight regain following Roux-en-Y gastric bypass vol.14, pp.2, 2018, https://doi.org/10.1080/17446651.2019.1571907
  3. Endoscopic bariatric treatments : new toolkit in the armamentarium against obesity vol.30, pp.2, 2018, https://doi.org/10.1097/mol.0000000000000585
  4. An Approach to Obesity Management for Gastroenterologists and Hepatologists vol.17, pp.4, 2018, https://doi.org/10.1007/s11938-019-00250-5
  5. Safety and Feasibility of a Novel Endoscopic Suturing Device (EndoZip TM) for Treatment of Obesity: First-in-Human Study vol.30, pp.5, 2018, https://doi.org/10.1007/s11695-019-04370-w
  6. Common and Uncommon Problems During Endoscopic Suturing With Apollo Overstitch: Tips and Tricks for Troubleshooting vol.23, pp.3, 2018, https://doi.org/10.1016/j.tige.2021.03.001
  7. Advanced Endoscopy Training in the United States: An Advanced Fellow's Perspective vol.8, pp.5, 2018, https://doi.org/10.14309/crj.0000000000000612
  8. Endobariatric procedures for obesity: clinical indications and available options vol.14, pp.None, 2021, https://doi.org/10.1177/2631774520984627
  9. How to Incorporate Bariatric Training Into Your Fellowship Program vol.161, pp.1, 2018, https://doi.org/10.1053/j.gastro.2021.04.030